AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Stars over Athens: The who’s who at Calcalist's first Israel-Greece conference
2
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
3
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
4
Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers
5
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
More news

Kamada

4 stories about Kamada
עובדים ב מפעל של קמהדע

Israeli company Kamada to offer antibody treatment to Covid-19 patients

17.06.20|Hagar Ravet
“To the best of our knowledge, Kamada is the first company globally to complete manufacturing of a plasma-derived IgG product for the treatment of Covid-19,” says CEO of the Nasdaq listed company
עמיר לונדון מנכ"ל קמהדע

FIMI Makes $25 Million Private Placement in Biomed Company Kamada

22.01.20|Tzally Greenberg
Israel-based private equity fund FIMI became the largest shareholder in Nasdaq and Tel Aviv-listed Kamada in November
עובדים ב מפעל של קמהדע

FIMI Becomes Biggest Shareholder in Biomed Company Kamada

24.11.19|Golan Hazani and Tzally Greenberg
Nasdaq and Tel Aviv-listed Kamada develops protein-based pharmaceuticals for genetic disorders, as well as rabies antibodies and a serum against snake bites
עמיר לונדון מנכ"ל קמהדע

Developer Of Anti-Rabies Drug Jumps on FDA Approval

27.08.17|Dror Reich
The plasma-derived drug is used together with the rabies vaccine to treat unvaccinated persons exposed to the virus